Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3
Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
- Status
- COMPLETED
- Phase
- PHASE4
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination
- Status
- UNKNOWN
- Phase
- PHASE4
Improving Antimicrobial-Prescribing in Emergency Departments
- Status
- COMPLETED
- Phase
- NA
DPX-Survivac and Checkpoint Inhibitor in DLBCL
- Status
- COMPLETED
- Phase
- PHASE2
Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)
- Status
- COMPLETED
- Phase
- N/A
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
- Status
- COMPLETED
- Phase
- PHASE4
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fecal Microbiota Transplant (FMT) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
The Medicines Optimisation Review Toolkit Evaluation in HIV Outpatients
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab as Neoadjuvant Treatment in HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
- Status
- COMPLETED
- Phase
- PHASE1